Head-to-head · free

908 Devices Inc. vs Merck

MASS vs MRK — return on capital, cash generation, margins and balance sheet side by side.

MASS

0 / 8

measures where MASS leads

MRK

8 / 8

measures where MRK leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureMASS · FY2025MRK · FY2025
Revenue$56.2M$65.0B
Net income$19.5M$18.3B
Revenue growth (yearly, multi-year)7.4%7.5%
Free cash flow(24.6M)$12.4B
Free cash flow margin-43.9%19.0%
Net cash / (debt)——
ROIC—19.0%
Return on equity15.1%36.9%
Gross margin50.6%74.8%
Operating margin-45.7%34.0%
Net debt / EBITDA—1.29x

Figures are as reported by each company; latest fiscal year shown.

Where 908 Devices Inc.'s cash went (FY2025)

Capital spending
$955000
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full MASS profile →

Where Merck's cash went (FY2025)

Capital spending
$4.1B
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full MRK profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons